المؤلفون: Kambayashi, Atsushi¹ (AUTHOR) kambayashi@rs.tus.ac.jp, Iida, Masaki¹ (AUTHOR), Ishihara, Makoto¹ (AUTHOR), Takahashi, Yoshinori¹ (AUTHOR), Abrahamsson, Bertil² (AUTHOR), Charoo, Naseem A.³ (AUTHOR), Cristofoletti, Rodrigo⁴ (AUTHOR), Langguth, Peter⁵ (AUTHOR), Mehta, Mehul⁶ (AUTHOR), Parr, Alan⁷ (AUTHOR), Polli, James E.⁸ (AUTHOR), Shah, Vinod P.⁹ (AUTHOR), Dressman, Jennifer¹⁰ (AUTHOR)

المصدر: Journal of Pharmaceutical Sciences. Nov2024, Vol. 113 Issue 11, p3137-3144. 8p.

مصطلحات موضوعية: *SOLID dosage forms, *RALTEGRAVIR, *POTASSIUM, *BIOPHARMACEUTICS, *SOLUBILITY, *HIV

المؤلفون: Westman, ME¹ (AUTHOR) mark.westman@sydney.edu.au, Hall, E¹ (AUTHOR), Norris, JM^1,2 (AUTHOR), Meili, T³ (AUTHOR), Hofmann‐Lehmann, R³ (AUTHOR), Malik, R^4,5 (AUTHOR)

المصدر: Australian Veterinary Journal. Sep2024, Vol. 102 Issue 9, p453-465. 13p.

مصطلحات موضوعية: *RALTEGRAVIR, *REVERSE transcriptase inhibitors, *RETROVIRUS diseases, *HIV, *CHIMERIC proteins, *VETERINARY medicine

المصدر: A Randomized Comparative Phase II Trial Evaluating the Capacity of the Dual Combination Doravirine/Raltegravir to Maintain Virological Success in HIV-1 Infected Patients With an HIV-RNA Plasma Viremia Below 50 Copies/mL Under a Current Antiretroviral Regimen

المؤلفون: Núñez, Isaac^1,2,3 (AUTHOR) isaac.nunezs@incmnsz.mx, Caro-Vega, Yanink⁴ (AUTHOR), MacDonald, Conor³ (AUTHOR), Mosqueda-Gómez, Juan Luis⁵ (AUTHOR), Piñeirúa-Menéndez, Alicia⁶ (AUTHOR), Matthews, Anthony A³ (AUTHOR) isaac.nunezs@incmnsz.mx

المصدر: Open Forum Infectious Diseases. Aug2024, Vol. 11 Issue 8, p1-8. 8p.

مصطلحات موضوعية: *VIRAL load, *RALTEGRAVIR, *ANTIRETROVIRAL agents, *CAUSAL inference, *DOLUTEGRAVIR

المؤلفون: Saint‐Lary, Laura¹ laura.saint‐lary@inserm.fr, Lacroix, Isabelle^1,2, Leroy, Valériane¹, Sommet, Agnès^1,2

المصدر: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-12. 12p.

مصطلحات موضوعية: *RALTEGRAVIR, *INTEGRASE inhibitors, *CONGENITAL disorders, *HUMAN abnormalities, *DRUG side effects, *PRENATAL drug exposure

المؤلفون: Ayenew, Getahun¹ (AUTHOR), Agumas, Yeshambel² (AUTHOR), Shibabaw, Tebkew³ (AUTHOR), Getaneh, Gebremariam⁴ (AUTHOR), Getie, Michael⁵ (AUTHOR) mgetachew286@gmail.com

المصدر: PLoS ONE. 7/9/2024, Vol. 19 Issue 7, p1-15. 15p.

مصطلحات موضوعية: *RALTEGRAVIR, *HIV, *ANTIRETROVIRAL agents, *MEDICAL disclosure, *CASE-control method, *VIRAL load, *PATIENT compliance

مصطلحات جغرافية: ETHIOPIA, SAHARA

المساهمون: Carlos Brites, Senior Investigator

المصدر: Evaluation of the Use of Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection in Pregnant Women Presenting With Detectable Viral Load After 32 Weeks of Gestation: a Pilot Study

Other URLs: http://www.fbai.com.br

المؤلفون: Chen, Guan-Jhou^1,2 (AUTHOR), Cheng, Chien-Yu^3,4 (AUTHOR), Yang, Chia-Jui^5,6 (AUTHOR), Lee, Nan-Yao⁷ (AUTHOR), Tang, Hung-Jen⁸ (AUTHOR), Huang, Sung-Hsi^9,10 (AUTHOR), Huang, Miao-Hui¹¹ (AUTHOR), Liou, Bo-Huang¹² (AUTHOR), Lee, Yi-Chien¹³ (AUTHOR), Lin, Chi-Ying¹⁴ (AUTHOR), Hung, Tung-Che¹⁵ (AUTHOR), Lin, Shih-Ping¹⁶ (AUTHOR), Sun, Hsin-Yun¹ (AUTHOR), Chang, Sui-Yuan^17,18 (AUTHOR), Hung, Chien-Ching^1,10,14 (AUTHOR) hcc0401@ntu.edu.tw, Group, Taiwan HIV Study (AUTHOR)

المصدر: Journal of Antimicrobial Chemotherapy (JAC). May2024, Vol. 79 Issue 5, p1157-1163. 7p.

مصطلحات موضوعية: *RALTEGRAVIR, *INTEGRASE inhibitors, *DRUG resistance, *HIV, *CD4 lymphocyte count, *ANTI-HIV agents

مصطلحات جغرافية: TAIWAN

الشركة/الكيان: STANFORD University

المؤلفون: Pimentel, Victor¹ (AUTHOR) martapingarilho@ihmt.unl.pt, Pingarilho, Marta¹ (AUTHOR) cruzsebastiao@ihmt.unl.pt, Sebastião, Cruz S.^1,2,3 (AUTHOR) mafaldansmiranda@ihmt.unl.pt, Miranda, Mafalda¹ (AUTHOR) mrfom@ihmt.unl.pt, Gonçalves, Fátima⁴ (AUTHOR) mfmgoncalves@chlo.min-saude.pt, Cabanas, Joaquim⁴ (AUTHOR) jcabanas@chlo.min-saude.pt, Costa, Inês⁴ (AUTHOR) icosta@chlo.min-saude.pt, Diogo, Isabel⁴ (AUTHOR) Ifmadeira@chlo.min-saude.pt, Fernandes, Sandra⁴ (AUTHOR) smfernandes@chlo.min-saude.pt, Costa, Olga⁵ (AUTHOR) ompena@netcabo.pt, Corte-Real, Rita⁵ (AUTHOR) cortereal.rita@gmail.com, Martins, M. Rosário O.¹ (AUTHOR) sgseabra@ihmt.unl.pt, Seabra, Sofia G.¹ (AUTHOR) ana.abecasis@ihmt.unl.pt, Abecasis, Ana B.¹ (AUTHOR), Gomes, Perpétua^4,6 (AUTHOR) pcrsilva@chlo.min-saude.pt

المصدر: Viruses (1999-4915). Apr2024, Vol. 16 Issue 4, p622. 15p.

مصطلحات موضوعية: *RALTEGRAVIR, *DRUG resistance, *NON-nucleoside reverse transcriptase inhibitors, *NUCLEOTIDE sequencing, *HIV, *REVERSE transcriptase inhibitors

مصطلحات جغرافية: PORTUGAL

المؤلفون: Tumwegamire, Adah¹ (AUTHOR), Fatch, Robin² (AUTHOR), Emenyonu, Nneka I.² (AUTHOR), Lodi, Sara³ (AUTHOR), Muyindike, Winnie R.^1,4 (AUTHOR), Kekibiina, Allen¹ (AUTHOR), Adong, Julian¹ (AUTHOR), Ngabirano, Christine¹ (AUTHOR), Beesiga, Brian⁵ (AUTHOR), Marson, Kara² (AUTHOR), Golabi, Nakisa² (AUTHOR), Kamya, Moses⁵ (AUTHOR), Chamie, Gabriel² (AUTHOR), Hahn, Judith A.^2,6 (AUTHOR) Judy.hahn@ucsf.edu

المصدر: PLoS ONE. 3/20/2024, Vol. 19 Issue 3, p1-14. 14p.

مصطلحات موضوعية: *RALTEGRAVIR, *HIV, *MYCOBACTERIUM tuberculosis, *ALCOHOLISM, *LATENT tuberculosis, *ANTIRETROVIRAL agents, *SMOKING, *CD4 lymphocyte count

مصطلحات جغرافية: UGANDA, SUB-Saharan Africa

المؤلفون: Merck Sharp & Dohme LLC

المساهمون: Vadim Pokrovsky, Professor

المصدر: Efficacy and Safety of an Initial Regimen Raltegravir (RAL) + Lamivudine/Abacavir Fixed-Dose Combination (3TC/ABC FDC) for 48 Weeks in ART- naïve, HIV/TB Co-Infected Adult Subjects Receiving Rifabutin-containing, 1-line Anti-TB Therapy

المؤلفون: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH)

المصدر: Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study
Persaud D, Bryson Y, Nelson BS, Tierney C, Cotton MF, Coletti A, Jao J, Spector SA, Mirochnick M, Capparelli EV, Costello D, Szewczyk J, Nicodimus N, Stranix-Chibanda L, Kekitiinwa AR, Korutaro V, Reding C, Carrington MN, Majji S, Yin DE, Jean-Philippe P, Chadwick EG. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024 Jan;11(1):e20-e30. doi: 10.1016/S2352-3018(23)00236-9. Epub 2023 Dec 4.
Nelson BS, Tierney C, Persaud D, Jao J, Cotton MF, Bryson Y, Coletti A, Ruel TD, Spector SA, Reding C, Bacon K, Costello D, Perlowski C, Santos Cruz ML, Kosgei J, Majji S, Yin DE, Jean-Philippe P, Chadwick EG; IMPAACT P1115 Team. Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life. Clin Infect Dis. 2023 Feb 8;76(3):e744-e747. doi: 10.1093/cid/ciac695.
Ruel TD, Capparelli EV, Tierney C, Nelson BS, Coletti A, Bryson Y, Cotton MF, Spector SA, Mirochnick M, LeBlanc R, Reding C, Zimmer B, Persaud D, Bwakura-Dangarembizi M, Naidoo KL, Hazra R, Jean-Philippe P, Chadwick EG. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021 Mar;8(3):e149-e157. doi: 10.1016/S2352-3018(20)30274-5. Epub 2020 Nov 23.

المؤلفون: Merck Sharp & Dohme LLC

المصدر: Pharmacokinetics Distribution of Raltegravir Using Radiolabeling in HIV-infected Patients by PET/MR: a Pilot Study.

المؤلفون: De Bellis, Emanuela, Donnarumma, Danilo, Zarrella, Adele, Mazzeo, Salvatore Maria, Pagano, Annarita, Manzo, Valentina, Mazza, Ines, Sabbatino, Francesco, Corbi, Graziamaria, Pagliano, Pasquale, Filippelli, Amelia, Conti, Valeria

المصدر: Pharmaceutics; Jan2025, Vol. 17 Issue 1, p31, 46p

مصطلحات موضوعية: HIGHLY active antiretroviral therapy, REVERSE transcriptase inhibitors, DRUG registration, INTEGRASE inhibitors, HIV-positive persons, RALTEGRAVIR

المؤلفون: Marcelin, Anne-Geneviève, Soulie, Cathia, Wirden, Marc, Barriere, Guillaume, Durand, François, Charpentier, Charlotte, Descamps, Diane, Calvez, Vincent

المصدر: Journal of Antimicrobial Chemotherapy (JAC); Jan2025, Vol. 80 Issue 1, p95-101, 7p

مصطلحات موضوعية: NON-nucleoside reverse transcriptase inhibitors, NUCLEOSIDE reverse transcriptase inhibitors, REVERSE transcriptase inhibitors, ANTIRETROVIRAL agents, VIRAL load, RALTEGRAVIR

المؤلفون: Yan, Lei, Henegar, Cassidy E., Marconi, Vincent C., Gordon, Kirsha S., Hicks, Charles, Vannappagari, Vani, Justice, Amy C., Aslan, Mihaela

المصدر: AIDS Research & Therapy; 12/21/2024, Vol. 21 Issue 1, p1-13, 13p

مصطلحات موضوعية: HIV integrase inhibitors, DARUNAVIR, RESEARCH funding, ANTIRETROVIRAL agents, HIV-positive persons, RALTEGRAVIR, LOGISTIC regression analysis, HIV infections, DESCRIPTIVE statistics, DRUG approval, LONGITUDINAL method, VETERANS, NUCLEOSIDE reverse transcriptase inhibitors

المؤلفون: Nikfarjam, Zahra, Rakhshi, Reza, Zargari, Farshid, Aalikhani, Mahdi, Hasan-Abad, Amin Moradi, Bazi, Zahra

المصدر: Scientific Reports; 12/5/2024, Vol. 14 Issue 1, p1-17, 17p

مصطلحات موضوعية: DRUG repositioning, MOLECULAR dynamics, MOLECULAR docking, RALTEGRAVIR, GROWTH factors

المؤلفون: Gouissi Anguechia, Davy-Hyacinthe, Bouba, Yagai, Semengue, Ezechiel Ngoufack Jagni, Ka'e, Aude Christelle, Takou, Désiré, Ambe Chenwi, Collins, Beloumou, Grace, Nka, Alex Durand, Basseck Wome, Ulrich Roland, Santoro, Maria Mercedes, Ceccherini-Silberstein, Francesca, Chatté, Adawaye, Montesano, Carla, Cappelli, Giulia, Colizzi, Vittorio, Ndjolo, Alexis, Mbanya, Dora, Ndembi, Nicaise, Perno, Carlo-Federico, Fokam, Joseph

المصدر: Viruses (1999-4915); Dec2024, Vol. 16 Issue 12, p1853, 12p

مصطلحات موضوعية: NON-nucleoside reverse transcriptase inhibitors, REVERSE transcriptase inhibitors, PATIENT compliance, MIDDLE-income countries, TREATMENT failure, RALTEGRAVIR

المؤلفون: Zahra Nikfarjam, Reza Rakhshi, Farshid Zargari, Mahdi Aalikhani, Amin Moradi Hasan-Abad, Zahra Bazi

المصدر: Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)

مصطلحات موضوعية: ADAM17, Drug repurposing, Molecular docking, Molecular Dynamics, Raltegravir, Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-2322

URL الوصول: https://doaj.org/article/0cbd04ace8f847cdb8db9752ef31a019

المؤلفون: Minja, Makyao¹ (AUTHOR), Mbilinyi, Tusaligwe² (AUTHOR), Mkinga, Bryceson³ (AUTHOR), Philipo, Erick G.⁴ (AUTHOR), Owenya, Joyce⁵ (AUTHOR), Kilonzi, Manase¹ (AUTHOR) manasekilonzi@gmail.com

المصدر: PLoS ONE. 2/27/2024, Vol. 19 Issue 2, p1-11. 11p.

مصطلحات موضوعية: *RALTEGRAVIR, *HIV-positive persons, *INTEGRASE inhibitors, *PATIENT compliance, *MENINGITIS, *MARITAL status

مصطلحات جغرافية: TANZANIA, DAR es Salaam (Tanzania)